Hologic Acquires Acessa To Add ProVu Fibroid Treatment

Hologic has agreed to pay $80m in cash, plus contingent payments for Acessa, a privately held developer of minimally invasive treatments for uterine fibroids.

MT2008_M-A_414545491_1200.jpg
• Source: shutterstock.com

Hologic Inc. is improving its gynecology surgery business by acquiring Acessa Health Inc. for $80m, the companies announced on 26 August.

Acessa Health markets the ProVu system, which integrates a handheld laparoscopic radiofrequency ablation tool with intra-abdominal ultrasound visualization and guidance...

More from Deals

More from Business